XML 79 R21.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Business Segment, Geographic and Concentration Risk Information | 3 Months Ended
--- | ---
Mar. 29, 2013
Business Segment, Geographic and Concentration Risk Information [Abstract] |
BUSINESS SEGMENT, GEOGRAPHIC AND CONCENTRATION RISK INFORMATION | 15. BUSINESS SEGMENT, GEOGRAPHIC AND CONCENTRATION RISK INFORMATION The Company operates its business in two reportable segments – Implantable Medical and Electrochem. The Implantable Medical segment is comprised of Greatbatch Medical and QiG Group and designs and manufactures medical devices and components for the cardiac, neuromodulation, vascular and orthopaedic markets. The Implantable Medical segment offers complete medical devices including design, development, manufacturing, regulatory submission and supporting worldwide distribution, which is facilitated through the QiG Group and leverages the component technology of Greatbatch Medical. The devices designed and developed by the QiG Group are manufactured by Greatbatch Medical. The Implantable Medical segment also offers individual components for implantable medical devices as well as value-added assembly and design engineering services for its component products. Examples of these components include batteries, capacitors, filtered and un-filtered feedthroughs, machined components, enclosures, leads, introducers, catheters, as well as orthopaedic implants, instruments and cases and trays. Electrochem is an industry leader in designing and manufacturing total power solutions for critical applications with market-leading OEMs, largely in the portable medical and energy space. Electrochem offers its customers components, consultation, design, development and testing for medical device applications, in high-value markets, including those that support the transition of delivery of health care from clinical to outpatient and home settings, as well as those that enhance the quality of life for an aging population. Examples of these devices include powered surgical tools, automated external defibrillators, portable ultrasound devices, portable oxygen concentrators, and ventilators, among others. Electrochem provides cell and battery pack configurations for rechargeable and non-rechargeable battery power systems, charging and docking stations, and power supplies, for devices where failure is not an option. The Company defines segment income from operations as sales less cost of sales including amortization and expenses attributable to segment-specific selling, general, administrative, research, development, engineering and other operating activities. Segment income also includes a portion of non-segment specific selling, general, and administrative expenses based on allocations appropriate to the expense categories. The remaining unallocated operating and other expenses are primarily administrative corporate headquarters' expenses and capital costs that are not allocated to reportable segments. Transactions between the two segments are not significant. An analysis and reconciliation of the Company's business segment, product line and geographic information to the respective information in the Condensed Consolidated Financial Statements follows. Sales by geographic area are presented by allocating sales from external customers based on the location to which products are shipped (in thousands):
|  |  |  | Three Months Ended |
|  |  |  | March 29, |  | March 30, |
| Sales: | 2013 |  | 2012 |
| Implantable Medical |  |  |  |  |  |
|  | Cardiac/Neuromodulation | $ | 71,167 |  | $ | 75,135 |
|  | Vascular |  | 10,624 |  |  | 11,636 |
|  | Orthopaedic |  | 29,623 |  |  | 31,046 |
|  |  | Total Implantable Medical |  | 111,414 |  |  | 117,817 |
| Electrochem |  |  |  |  |  |
|  | Portable Medical |  | 18,889 |  |  | 18,720 |
|  | Energy |  | 12,293 |  |  | 14,771 |
|  | Other |  | 5,669 |  |  | 7,795 |
|  |  | Total Electrochem |  | 36,851 |  |  | 41,286 |
|  |  | Total sales | $ | 148,265 |  | $ | 159,103 |
|  |  |  | Three Months Ended |
|  |  |  | March 29, |  | March 30, |
|  | 2013 |  | 2012 |
| Segment income from operations: |  |  |  |  |  |
|  | Implantable Medical | $ | 14,343 |  | $ | 10,112 |
|  | Electrochem |  | 4,816 |  |  | 4,471 |
| Total segment income from operations |  | 19,159 |  |  | 14,583 |
| Unallocated operating expenses |  | (4,820) |  |  | (3,385) |
| Operating income as reported |  | 14,339 |  |  | 11,198 |
| Unallocated other expense |  | (7,273) |  |  | (5,079) |
| Income before provision for income taxes | $ | 7,066 |  | $ | 6,119 |
|  |  |  | Three Months Ended |
|  |  |  | March 29, |  | March 30, |
|  | 2013 |  | 2012 |
| Sales by geographic area:
|  | United States | $ | 71,334 |  | $ | 82,406 |
| Non-Domestic locations: |  |  |  |  |  |
|  | Puerto Rico |  | 28,498 |  |  | 23,540 |
|  | Belgium |  | 17,671 |  |  | 15,338 |
|  | United Kingdom & Ireland |  | 7,536 |  |  | 12,357 |
|  | Rest of world |  | 23,226 |  |  | 25,462 |
|  |  | Total sales | $ | 148,265 |  | $ | 159,103 |
| Three customers accounted for a significant portion of the Company’s sales as follows:
|  |  |  | Three Months Ended |
|  |  |  | March 29, |  | March 30, |
|  | 2013 |  | 2012 |
| Customer A |  | 19% |  |  | 20% |
| Customer B |  | 18% |  |  | 13% |
| Customer C |  | 15% |  |  | 10% |
|  | Total |  | 52% |  |  | 43% |
| Long-lived tangible assets by geographic area are as follows (in thousands):
|  | As of
|  |  | March 29, |  |  | December 28,
|  |  | 2013 |  |  | 2012
| United States | $ | 121,460 |  | $ | 123,104
| Rest of world |  | 29,072 |  |  | 27,789
| Total | $ | 150,532 |  | $ | 150,893

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration